BioGaia AB (publ) BioGaia AB (publ)

BioGaia AB (publ)

BIOG-B

Rank in Stocks #8043
BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in... BioGaia AB (publ), a Swedish enterprise founded in 1990 and headquartered in Stockholm, is dedicated to the worldwide development, marketing, and distribution of probiotic products renowned for their scientifically proven health advantages. The company operates through three primary divisions. Its Pediatrics segment offers various items such as drops, oral rehydration solutions, and gut health tablets, in addition to supplying cultures for integration into infant formula. The Adult Health segment provides gut health tablets and oral health lozenges, alongside furnishing cultures to licensees for use in dairy products. A third segment, "Other," specializes in packaging solutions. BioGaia's extensive product portfolio targets a range of health issues, including infantile colic and digestive health in children, antibiotic-associated and acute diarrhea, gingivitis, periodontal disease, general well-being, Helicobacter pylori bacterial infections (linked to gastric ulcers), and concerns related to low bone density. All of its offerings are sold exclusively under the BioGaia brand.
Share Price
$13.10
Market Cap
$1.29B
Change (1 day)
4.02%
Change (1 year)
14.92%
Country
SE
Trade BioGaia AB (publ) (BIOG-B)

Category

Healthcare
Stock price history for BioGaia AB (publ) (BIOG-B)
Highest end of day price: $12.35 on 2026-10-01

Lowest end of day price: $6.50 on 2015-09-01
Stock price history of BioGaia AB (publ) from 2015 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) 6.08%
2025 -0.98%
2024 9.23%
2023 17.14%
2022 -25.15%
2021 -12.80%
2020 58.73%
2019 5.53%
2018 53.85%
2016 -32.67%
2015 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$165.48 23.75%
DE
$40.45 43.11%
JP
$224.75 31.24%
CH
$18.43 -4.03%
IN